Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
11/26/2003 | CN1457783A Sparxacin dripping pill for resisting bacterial infection and its preparing method |
11/26/2003 | CN1457782A Dry spaxxacin suspension agent for resisting bacterial infection and its preparing method |
11/26/2003 | CN1457781A Cetirizing hydrochloride cataplasm preparation |
11/26/2003 | CN1457779A Medicinal composition for curing trachitis |
11/26/2003 | CN1457776A Self emulsified soft capsule of ginkgo leaf extract and its preparing method |
11/26/2003 | CN1457773A Biguanide vanadium complex granular powder and/or capsule for curing diabetes and its use |
11/26/2003 | CN1457772A Injection for curing acute lung injury and acute respirotary distress syndrome |
11/26/2003 | CN1457770A Anti-virus arosol inhalation medicine liquid |
11/26/2003 | CN1457769A Self adhesive medical medicine plaster |
11/26/2003 | CN1457768A Compound tablet capable of controlling release of effective component after oral administration |
11/26/2003 | CN1457767A Method for preparing traditional Chinese medicine concentrated pill |
11/26/2003 | CN1457766A Mucilage antiseptic medicine composition capable of being locally administratied and sustainably released and its preparing method |
11/26/2003 | CN1457765A Cetirizine hydrochloride gel |
11/26/2003 | CN1457688A Brain strengthening chewing tablet for child |
11/26/2003 | CN1128885C Method for drying lactulose solution |
11/26/2003 | CN1128704C Method for producing layered product |
11/26/2003 | CN1128658C Method of mixing or dispersing liquid |
11/26/2003 | CN1128636C Pharmaceutical angiostatic dipeptide compositions and method of use thereof |
11/26/2003 | CN1128635C Amber anti-inflammatory pain-stopping powder medicine |
11/26/2003 | CN1128633C Exterior-applied medicine for treating gynopathy |
11/26/2003 | CN1128631C External-use medicinal plaster for curing bone disease |
11/26/2003 | CN1128627C Plaster for treating rheumatism and its preparing method |
11/26/2003 | CN1128619C Utilization of powder prepns. contg. hydroxypyridones treating leg ulcer and decubitus ulcers |
11/26/2003 | CN1128618C Use of histamine for elevating blood histamine |
11/26/2003 | CN1128615C Pharmaceutical compositions for prevention and treatment of cancerous disease and process for their preparation |
11/26/2003 | CN1128614C Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation and preparation containing it |
11/26/2003 | CN1128612C Pharmaceutical composition with base of rhein or diacerhein with improved biological availability |
11/25/2003 | US6653481 Used as calcium channel blockers |
11/25/2003 | US6653427 Introducing monomeric 2-hydroxyethyl methacrylate containing ethylene glycol dimethacrylate impurities in the range of 0.05 to 0.1% by weight with hydroxybutyl acrylate into a solution of water and alcohol, copolymerizing; gel-free |
11/25/2003 | US6653426 Polymer compositions for intraluminal stent |
11/25/2003 | US6653352 Pain reliever and method of use |
11/25/2003 | US6653339 Method of treating irritable bowel syndrome |
11/25/2003 | US6653329 Granulated pharmaceutical formulations and methods for making the same |
11/25/2003 | US6653292 Stimulating Th1 pattern of immune activation, cytokine production, NK lytic activity and B cell proliferation; modulating with nucleic acid sequences containing unmethylated CpG dinucleotides |
11/25/2003 | US6653285 Polypeptide inhibitors and enhancers of glycosaminoglycans such as hyaluronic acid, chondroitin sulfate, dermatan sulfate, heparin, keratan sulfate, chitin and chitosans; antiinflammatory and anticarcinogenic agents; infections |
11/25/2003 | US6653284 Keratinocyte growth factor-2 formulations |
11/25/2003 | US6653281 Ring modified cyclic peptide analogs |
11/25/2003 | US6652967 Nano-dispersed powders and methods for their manufacture |
11/25/2003 | US6652903 Dry-copying method for producing flat, individually dosed preparations of active agents |
11/25/2003 | US6652902 Water soluble polymers comprising phenylboronic acid crosslinked by mixing in water with polymers containing hydroxy/carboxy groups; useful in prevention of adhesions, as sealants, and for controlled drug delivery |
11/25/2003 | US6652895 Carbohydrate matrix |
11/25/2003 | US6652890 Treating cancer cells that express a membrane protein tNOX, a hormone-insensitive and drug-responsive form of NOX (NADH oxidase) specific to cancer cells |
11/25/2003 | US6652886 Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents |
11/25/2003 | US6652885 Complexing drug with diketopiperazine; washing; separation of impurities |
11/25/2003 | US6652884 Method for the treatment of solid tumors by albumin microparticles incorporating paclitaxel |
11/25/2003 | US6652882 Containing uncrosslinked polymer, crosslinked insoluble polymer or mixture |
11/25/2003 | US6652881 Micronized, quick dissolving; water, polysorbate 80 and sodium lauryl sulfate |
11/25/2003 | US6652880 Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants |
11/25/2003 | US6652879 Improving the palatability of fish oil medicinals; gelatin, gelatin softener, water and water soluble flavoring agent |
11/25/2003 | US6652877 With lipid or liposomal compounds |
11/25/2003 | US6652876 Active substance patch, kind to the skin, for transdermal administration of nonsteroidal antirheumatics |
11/25/2003 | US6652875 Casein formulations for the delivery of bioactive constituents |
11/25/2003 | US6652874 Pharmaceutical preparations and methods for their regional administration |
11/25/2003 | US6652873 Compositions and methods for enhancing receptor-mediated cellular internalization |
11/25/2003 | US6652865 For decreasing the effect of intestinal metabolism on a drug |
11/25/2003 | US6652850 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
11/25/2003 | US6652840 Aluminum chloride, ferric sulfate, regenerated oxidized cellulose, aluminum ammonium sulfate, absorbable gelatin and solvent; easy to use; reducing heart rate stimulation, staining, acid irritations and adhesive interference |
11/25/2003 | US6652839 Chewing gum with liquid medium |
11/25/2003 | US6652838 Method for treating diabetes mellitus |
11/25/2003 | US6652837 Preparation of novel particles for inhalation |
11/25/2003 | US6652575 Stent with smooth ends |
11/25/2003 | US6652510 Implantable infusion device and reservoir for same |
11/25/2003 | CA2268887C Closure system for an active agent delivery device |
11/25/2003 | CA2258811C Formulation for use in the prevention of pathogen induced diseases including hiv and hsv |
11/25/2003 | CA2119145C Ferrite particles and therapeutic and diagnostic uses therefore |
11/21/2003 | CA2385529A1 Stable dosage forms comprising atorvastatin calcium |
11/20/2003 | WO2003096017A1 Methods and compositions for inducing an immune response |
11/20/2003 | WO2003095641A1 Intracellular protein delivery compositions and methods of use |
11/20/2003 | WO2003095569A1 Capsules printed with sepia colored containing inks |
11/20/2003 | WO2003095548A1 Modified polymeric films |
11/20/2003 | WO2003095498A1 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process |
11/20/2003 | WO2003095479A1 Multiple branch peptide constructions comprising from 2 to 16 branches of the peptide rqgys or from 8 to 16 branches of the peptide rqgy providing from the hiv gp41 glycoprotein |
11/20/2003 | WO2003095464A1 Phosphatidyl oligo glycerins and structural analogs |
11/20/2003 | WO2003095085A1 Colloidal dispersion of calcium phosphate nanoparticles and at least one protein, and corresponding redispersible and calcined nanoparticles, preparation method and uses |
11/20/2003 | WO2003095029A1 Bisphosphonic acid for the treatment and prevention of osteoporosis |
11/20/2003 | WO2003095012A1 Method and apparatus for vaporizing a compound |
11/20/2003 | WO2003095011A1 Medicament respiratory delivery device and cartridge |
11/20/2003 | WO2003094976A1 Lyophilized edible food incorporating a marker |
11/20/2003 | WO2003094971A1 Cationic lipids for intracellular delivery of bioactive substances |
11/20/2003 | WO2003094951A1 Soluble formulations comprising insulin aspart and insulin detemir |
11/20/2003 | WO2003094942A1 Soluble composition containing sporopollenin and the use thereof |
11/20/2003 | WO2003094941A1 Traditional chinese pharmaceutical formulation for treatment of paradentosis, process for preparation and use thereof |
11/20/2003 | WO2003094940A1 Medicament for prevention and treatment of fracture and osteoporosis |
11/20/2003 | WO2003094930A1 Embolization using degradable crosslinked hydrogels |
11/20/2003 | WO2003094925A1 Injectable bisphosphonate formulations |
11/20/2003 | WO2003094920A1 Microbicidal pyrimidine or triazine for preventing sexual hiv transmission |
11/20/2003 | WO2003094911A1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
11/20/2003 | WO2003094909A2 Methods and compositions for the treatment and prevention of intermittent claudication or alzheimer's disease |
11/20/2003 | WO2003094906A1 Anti-rhinovirus active agents |
11/20/2003 | WO2003094905A1 Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders |
11/20/2003 | WO2003094900A1 Delivery of drug amines through an inhalation route |
11/20/2003 | WO2003094899A1 Novel method of preparing programmed-release compositions containing (s)-1-[n-[1-(ethoxycarbonyl)-3-phenylpropyl]-l-alanyl]-l-proline and the product thus obtained |
11/20/2003 | WO2003094898A2 Microcapsules containing biomedical materials |
11/20/2003 | WO2003094897A1 Photostabilized soft capsule |
11/20/2003 | WO2003094896A1 A method to improve surface properties of pharmaceutical tablets |
11/20/2003 | WO2003094895A1 Extended release tablets comprising felodipine |
11/20/2003 | WO2003094894A1 Nanoparticulate nystatin formulations |
11/20/2003 | WO2003094893A1 Process for preparing an injection type solid chitosan powder |
11/20/2003 | WO2003094892A1 Conversion of amorphous material to a corresponding crystalline material by spray drying and utilization of the crystalline spray dried material in drug formulations |
11/20/2003 | WO2003094891A1 Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs |